Survival after embolization of the internal iliac arteries in ten patients with severe haematuria due to recurrent pelvic carcinoma

Clinical Radiology
C N Jenkins, J McIvor

Abstract

Therapeutic embolization of the internal iliac arteries is a well established technique for controlling severe haematuria caused by malignant disease, but there are few reports of the long term outcome. We performed iliac artery embolization procedures on 10 patients with severe haematuria secondary to widespread inoperable pelvic carcinoma, between 1979 and 1992, and have followed these patients until death. Prior to embolization, the mean transfusion requirement was 12 units (range 2-39 units). Survival ranged from 12h to 31 months (median 3.84 months). Five of the nine patients who survived more than 12h had complete relief of haematuria until their deaths, and only two patients required further blood transfusions. Our conclusions are that haematuria from inoperable pelvic carcinoma is usually controlled by therapeutic arterial embolization and that the duration of haematuria relief is usually life long.

Citations

Apr 9, 2008·Prostate Cancer and Prostatic Diseases·R ThurairajaD Sheehan
Oct 9, 2007·Obstetrics and Gynecology Clinics of North America·Filip BanovacJames Spies
Apr 29, 2006·BJU International·Barnaby J R BarrassRajendra A Persad
Oct 13, 2004·The Oncologist·Jose Pereira, Tien Phan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.